Atorvastatin Calcium
Product Images NDC 68071-3505

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-3505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3505 3)

Pdp (68071 3505 3)
The label for Atorvastatin Calcium 10mg tablets by NuCare Pharmaceuticals, Inc. displays the NDC 68071-3505-3 and indicates a package of 30 tablets. It is an oval-shaped, white to off-white film-coated tablet with 'C1' on one side and plain on the other. The label includes manufacturer Hydrobed Pharmaceuticals, Inc., lot and expiration placeholders, storage instructions at 68-77°F, and a warning to keep out of reach of children.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A line graph comparing the cumulative incidence (%) over time (years) between Atorvastatin and Placebo groups. The graph shows Atorvastatin with a lower cumulative incidence than Placebo, with a hazard ratio (HR) of 0.64 (0.50-0.83) and a p-value of 0.0005.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A line graph comparing cumulative hazard percentages over time (up to five years) for Atorvastatin versus placebo. The X-axis represents years to first primary endpoint, and the Y-axis shows cumulative hazard percentage. The graph includes a hazard ratio with confidence interval and p-value, illustrating statistical data relevant to Atorvastatin's effect relative to placebo.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
A line graph comparing the percentage of subjects experiencing an event over five years for Atorvastatin 10 mg versus 80 mg. The x-axis represents time to the first major cardiovascular endpoint in years, and the y-axis represents the percentage of subjects experiencing the event. The graph includes hazard ratio statistics for the comparison.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Atorvastatin Calcium, showing the molecular arrangement including aromatic rings, hydroxyl groups, and calcium ion with water molecules as part of the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.